RH5.1

BIOLOGICAL2 trials

Sponsors

University of Oxford

Conditions

Malaria,Falciparum

Phase 1

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

RecruitingNCT06958198

University of OxfordMalaria,Falciparum

Start: 2025-09-15End: 2026-10-01Target: 56Updated: 2026-03-11

Phase 2

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Active, not recruitingNCT07183371

University of OxfordMalaria,Falciparum

Start: 2025-12-15End: 2026-12-01Target: 360Updated: 2026-03-11